Study on Bioequivalence of Glucosamine Indometacin Enteric-coated Tablets in Healthy Volunteers

赵侠,王惠珍,周颖,孙培红,刘玉旺,赵东方,孙忠民,仲卫华

DOI: https://doi.org/10.3969/j.issn.1001-6821.2003.02.010

2003-01-01

Abstract:OBJECTIVE:To study the relative bioavailability and bioequivalence of glucosamine indometacin enteric-coated tablets in 20 healthy volunteers. METHODS: A single administration of 75 mg test and reference glucosamine indometacin enteric-coated tablets were given to 20 healthy male volunteers in randomized crossover study respectively. A high performance liquid chromatographic was developed to determine the concentration of indometacin in human serum. The data were analyzed by 3P97 program. RESULTS: The pharmacokinetics parameters after a single oral administration of 75 mg test and reference products were as follows: Cmax were 4.685 ± 1.168 mg-L-1 and 4.888±1.414 mg·L-1; tmax were 2.9 ± 1.2 h and 3.4 ± 0.9 h; AUC0-24 were 20.468 A 3.461 mg·h·L-1 and 20.415 ± 4.777 mg·h·L-1; AUC0-∞ were 2.908 ± 3.884 mg·h·L-1 and 23.151 ± 5.509 mg·h·L-1 The relative bioavailability of single oral administration group was ( 102.24±12.98 ) %. CONCLUSION: The tested and refered glucosamine indometacin enteric-coated tablets were bioequivalence.